Literature DB >> 1826517

Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.

E Edwards1, K Harkins, G Wright, F Henn.   

Abstract

The effects of learned helplessness on the 5-hydroxytryptamine (5-HT) uptake site were studied in rats using [3H]paroxetine binding. This ligand was chosen because it was demonstrated to label directly the 5-HT uptake site whereas the [3H]imipramine binding site has been demonstrated to be heterogeneous in nature. Moreover, [3H]imipramine appears to bind to a presynaptic recognition site different from the uptake site. Exposure to uncontrollable shock training and testing resulted in an overall increase in [3H]paroxetine binding in all the groups studied [nonhelpless (NLH), learned helpless (LH), spontaneously helpless (SPLH)] as compared to naive controls (NC). However, the increase in [3H]paroxetine binding was significantly higher in the LH and SPLH groups. The maximum number of [3H]paroxetine binding sites in the rat hippocampus was increased significantly in learned helpless rats (LH and SPLH) at day 4 and day 30 after the shock escape test as compared to NC and NLH rats. By contrast, in the rat hypothalamus the maximum number of [3H]paroxetine binding sites was reduced significantly in the LH rats as compared to naive controls and NLH rats during the same time course. There was no change in [3H]paroxetine binding sites in any other brain regions examined in LH, NLH, and NC rats. The results suggest that a hippocampal hypothalamic connection might play a role in the serotonergic mediation of learned helpless behavior.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826517     DOI: 10.1111/j.1471-4159.1991.tb02054.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  1 in total

1.  Psychotherapy and antidepressant treatment of depression: evidence for similar neurobiological mechanisms.

Authors:  Fritz A Henn; Emmeline Edwards; David Anderson; Barbara Vollmayr
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.